Profarma Recalls Vermox Tablets Due to Manufacturing Deviations
Profarma Distributors LLC is recalling 163 boxes of Vermox Tablets 100 mg due to CGMP deviations. The recall is voluntary and nationwide.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, which is a reasonable probability of temporary or medically reversible adverse health consequences. The source cites CGMP deviations without reporting specific illnesses or injuries, fitting the criteria for a moderate severity voluntary recall.
Plain-English summary
Profarma Distributors LLC is voluntarily recalling 163 boxes (978 tablets) of VERMOX Tablets 100 mg, 6-count boxes. The specific lot number is UPE187 with an expiration date of 08/17. The product was distributed nationwide.
The recall was initiated because of Current Good Manufacturing Practice (CGMP) deviations. This indicates that the product may not have been manufactured in accordance with FDA regulations regarding quality and safety controls. The recall was initiated on May 11, 2016, and was classified as Class II by the FDA.
Consumers who have this product should stop using it and contact Profarma Distributors LLC for instructions on how to return the product or obtain a refund. The recall was terminated on January 24, 2017.
The recalled product
- Product
- VERMOX Tablets 100 mg; 6-count box, UPC 7501109900619
- Manufacturer
- Profarma Distributors LLC
- Category
- Drug — Antiparasitic
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot # UPE187
- Exp. 08/17
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 5 recalled by Profarma Distributors LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 5 products in this recall →Related recalls
Same manufacturer · Profarma Distributors LLC
See all →- ModerateProfarma Recalls Vermox Tablets Due to Manufacturing Deviations
FDA (Drugs) · 2016-06-29
- ModerateProfarma Recalls tabcin ACTIVE M.R. Capsules Due to Manufacturing Deviations
FDA (Drugs) · 2016-06-29
- ModerateProfarma Recalls tabcin NOCHE Capsules Due to Manufacturing Deviations
FDA (Drugs) · 2016-06-29
- ModerateProfarma Recalls 1% Clotrimazole Cream Due to Manufacturing Deviations
FDA (Drugs) · 2016-06-29
Same hazard · cgmp deviation
See all →- SevereBaxter Recalls Vasopressin Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
- HighBaxter Recalls Clindamycin Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
- SevereBaxter Recalls Daptomycin Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
- ModerateLexia LLC Recalls Broadway Joe's Pain Cream Due to CGMP Deviations
FDA (Drugs) · 2026-09-09
- SevereBaxter Recalls Daptomycin Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
Similar recalls
- ModerateApotex Recalls Torsemide Tablets Due to Manufacturing Deviations
FDA (Drugs) · 2017-01-11
- ModeratePD-Rx Recalls Ibuprofen 200 mg Tablets Due to Manufacturing Deviations
FDA (Drugs) · 2018-02-07
- ModerateAlprazolam Tablets 1mg Recalled for CGMP Deviations
FDA (Drugs) · 2022-03-09
- ModerateFinasteride Tablets Recalled Nationwide for Manufacturing Practice Deviations
FDA (Drugs) · 2023-04-05
- ModerateVoriconazole Tablets 50mg Recalled Due to CGMP Deviations
FDA (Drugs) · 2025-04-16
- ModerateDrug Recall: Tadalafil 5 mg Tablets Due to Manufacturing Deviations
FDA (Drugs) · 2023-04-12